BioRegen
Company

Last deal

Amount

Series B

Stage

06.07.2010

Date

1

all rounds

General

About Company
BioRegen Biomedical is a Chinese company that develops biomaterials for various therapeutic indications, specializing in wound repair.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Bio Regen

founded date

01.01.2006

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Founded in 2008, BioRegen Biomedical focuses on developing hyaluronic acid-based products for ENT, orthopedics, and general surgeries. They utilize proprietary technology to create high-quality biomedical materials and regenerative medicines. The company's products are used for wound repair, endoscopic sinus surgery, and otology, ob-gyn, and orthopedic treatments. BioRegen Biomedical is committed to developing and commercializing innovative medical products for the Chinese market.